This company has been marked as potentially delisted and may not be actively trading. Impel Pharmaceuticals (IMPL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IMPL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Impel-Stelda Enters Primary Packaging Business of Tube FillingOctober 12, 2024 | msn.comImexpharm achieves net revenue of US$39.74 million in 2024H1July 26, 2024 | msn.comCompliant Marketing In The Pharmaceutical Industry's Regulatory MazeMay 17, 2024 | forbes.comImpel Pharmaceuticals Inc. (IMPLQ)March 13, 2024 | finance.yahoo.comImpel Pharma Mulls Sale, Signs Stalking Horse Deal; Files For Chapter 11 ProtectionDecember 19, 2023 | markets.businessinsider.comImpel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate SaleDecember 19, 2023 | finance.yahoo.comAdrian Adams steps down as CEO of Seattle's Impel PharmaceuticalsNovember 6, 2023 | bizjournals.comAnalysts Offer Insights on Healthcare Companies: Impel Pharmaceuticals (IMPL) and Relay Therapeutics (RLAY)October 9, 2023 | markets.businessinsider.comImpel Pharmaceuticals Announces Exploration of Strategic AlternativesOctober 5, 2023 | finance.yahoo.comImpel Pharmaceuticals (IMPL) Receives a Hold from JonesTradingSeptember 14, 2023 | markets.businessinsider.comImpel Pharmaceuticals (Nasdaq:IMPL) HeadlineTrading was temporarily halted for "IMPL" at 10:09 AM with a stated reason of "LULD pause."...September 13, 2023 | marketbeat.comImpel Pharmaceuticals (Nasdaq:IMPL) HeadlineTrading was temporarily halted for "IMPL" at 10:09 AM with a stated reason of "LULD pause."...September 13, 2023 | marketbeat.comWhy Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?September 8, 2023 | msn.comJonesTrading Reaffirms Their Hold Rating on Impel Pharmaceuticals (IMPL)August 22, 2023 | markets.businessinsider.comImpel Pharma Shares Tumble 46% After Breaching Terms of Credit AgreementAugust 16, 2023 | marketwatch.comImpel Pharma (NASDAQ:IMPL) Plummets on Viability ConcernsAugust 16, 2023 | msn.comWhy Is Impel Pharmaceuticals (IMPL) Stock Down 35% Today?August 16, 2023 | investorplace.comBiotech Catches Major Premarket BidJuly 5, 2023 | theglobeandmail.com84P.SG - Impel Pharmaceuticals IncJuly 3, 2023 | finance.yahoo.comDirector at Impel Pharmaceuticals Acquires Company Stock Options Worth 13,222 SharesJune 21, 2023 | benzinga.comImpel Pharmaceuticals Board Member Awarded $15K Worth of Stock OptionsJune 21, 2023 | benzinga.comImpel Pharmaceuticals Director Awarded $15K Worth of Stock OptionsJune 21, 2023 | benzinga.comImpel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache SocietyJune 15, 2023 | finance.yahoo.comImpel Pharmaceuticals (Nasdaq:IMPL) HeadlineTrading was temporarily halted for "IMPL" at 09:05 AM with a stated reason of "LULD pause."...May 17, 2023 | marketbeat.comImpel Pharmaceuticals Inc. (IMPL)May 17, 2023 | uk.finance.yahoo.comImpel Pharmaceuticals First Quarter 2023 Earnings: Misses ExpectationsMay 13, 2023 | finance.yahoo.comRecap: Impel Pharmaceuticals Q1 EarningsMay 12, 2023 | msn.comImpel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 12, 2023 | finance.yahoo.comEarnings Outlook For Impel PharmaceuticalsMay 11, 2023 | msn.comImpel Pharmaceuticals gets new CFOMay 10, 2023 | msn.comImpel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial OfficerMay 10, 2023 | finance.yahoo.comInvestors in Impel Pharmaceuticals (NASDAQ:IMPL) from a year ago are still down 67%, even after 26% gain this past weekMay 5, 2023 | finance.yahoo.comImpel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023May 5, 2023 | finance.yahoo.comImpel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine MedicationsApril 26, 2023 | finance.yahoo.comImpel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual MeetingApril 11, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Full-Year Results: Here's What Analysts Are Forecasting For This YearMarch 30, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Analysts Just Slashed This Year's Revenue Estimates By 12%March 26, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (IMPL) Reports Q4 Loss, Tops Revenue EstimatesMarch 24, 2023 | msn.comImpel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateMarch 24, 2023 | finance.yahoo.comImpel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023March 17, 2023 | finance.yahoo.comImpel Pharmaceuticals to Participate in Upcoming Investor Conferences in MarchMarch 3, 2023 | finance.yahoo.comImpel Pharma says reducing headcount by 16%, eliminating pipeline programsFebruary 24, 2023 | seekingalpha.comWhy Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionFebruary 23, 2023 | msn.comImpel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial OpportunityFebruary 22, 2023 | finance.yahoo.comImpel Pharmaceuticals Announces Strategic Reprioritization, Continues Focus on Maximizing Trudhesa® Commercial OpportunityFebruary 22, 2023 | finance.yahoo.comOcular Therapeutix (OCUL) Moves 35.1% Higher: Will This Strength Last?February 14, 2023 | nasdaq.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) to Post FY2027 Earnings of $1.16 Per Share, Wedbush ForecastsJanuary 26, 2023 | marketbeat.comImpel Pharmaceuticals Inc. (IMPL) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comImpel Pharmaceuticals Inc. (IMPL) Reports Q3 Loss, Lags Revenue EstimatesNovember 14, 2022 | nasdaq.com Get Impel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMPL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMPL Media Mentions By Week IMPL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMPL News Sentiment▼0.000.70▲Average Medical News Sentiment IMPL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMPL Articles This Week▼00▲IMPL Articles Average Week Get the Latest News and Ratings for IMPL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Impel Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CANF News Today UPC News Today ATXI News Today EVFM News Today VCNX News Today BPTH News Today HEPA News Today PTPI News Today VINC News Today SYRS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMPL) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Impel Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Impel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
